Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Heart. 2017 Jun 1;103(15):1185–1193. doi: 10.1136/heartjnl-2016-310450

Table 2.

Race-ethnicity specific association of tertiles of hepatocyte growth factor and cardiovascular disease risk factors

African American Chinese American Hispanic American Non-Hispanic white American
Characteristics Tertile 1 Tertile 2 Tertile 3 p Value Tertile 1 Tertile 2 Tertile 3 p Value Tertile 1 Tertile 2 Tertile 3 p Value Tertile 1 Tertile 2 Tertile 3 p Value
HGF Range (pg/mL) 342.6–813.9 814.3–999.6 1000.0–2151.8 292.4–738.3 738.3–892.1 892.4–2135.9 317.7–903.2 903.7–1112.9 1113.4–2094.1 313.6–783.5 783.6–993.1 993.2–2117.0
Age, years 59.1 (9.3) 62.3 (9.9) 65.0 (10.0) <0.001 57.9 (9.5) 62.6 (9.3) 66.6 (10.3) <0.001 58.0 (9.4) 61.3 (9.9) 64.3 (10.7) <0.001 59.3 (9.5) 62.6 (10.1) 65.9 (10.1) <0.001
Sex, % female 50 61 55 0.39 52 48 54 0.64 49 52 55 0.08 47 52 57 <0.001
Body Mass Index, kg/m2 29.3 (5.3) 30.4 (5.9) 30.7 (6.2) <0.001 23.2 (2.9) 24.2 (3.3) 24.5 (3.6) <0.001 28.2 (4.5) 29.2 (4.6) 30.9 (5.7) <0.001 26.4 (4.3) 27.6 (4.9) 29.2 (5.5) <0.001
Education <0.001 <0.001 0.33 <0.001
    ≤11th grade 9 11 15 16 26 33 39 50 46 3 5 7
    High school graduate 16 19 23 12 18 19 21 18 23 14 15 22
    Some college 35 34 36 25 16 19 30 22 24 23 29 33
    Bachelor’s degree 21 19 13 28 22 18 5 7 5 27 23 17
    Graduate/professional school 20 17 13 20 18 11 6 4 3 33 29 20
Income 0.002 0.08 0.10 <0.001
    < $25,000 22 32 37 41 49 60 44 50 55 11 14 23
    $25,000 – $50,000 31 32 34 22 21 23 35 33 31 23 26 32
    $50,000 – $100,000 37 27 23 24 19 12 19 15 12 33 35 30
    ≥ $100,000 10 9 6 13 11 6 3 3 2 33 25 15
Systolic Blood Pressure, mmHg 128.4 (20.0) 131.6 (22.2) 135.2 (22.1) 0.01 118.6 (18.8) 125.6 (21.7) 129.8 (22.7) 0.02 121.0 (19.4) 126.9 (21.2) 131.8 (23.2) <0.001 119.3 (18.7) 122.7 (19.9) 128.4 (21.7) <0.001
Hypertension, % Yes 49 59 70 <0.001 25 38 49 0.001 30 41 53 <0.001 29 36 50 <0.001
Diabetes Mellitus, % Yes 11 17 24 <0.001 6 13 20 <0.001 8 19 25 <0.001 2 5 11 <0.001
Total Cholesterol, mg/dL 190.0 (35.6) 192.8 (36.8) 186.0 (35.6) <0.001 194.0 (32.8) 190.1 (32.0) 194.1 (30.5) 0.47 202.4 (38.0) 200.9 (37.9) 191.6 (35.5) <0.001 195.3 (33.3) 197.3 (36.1) 194.9 (35.8) 0.31
HDL Cholesterol, mg/dL 54.1 (15.4) 52.3 (15.4) 50.8 (14.7) <0.001 51.3 (13.7) 49.1 (11.8) 48.1 (12.3) <0.001 49.2 (13.9) 47.4 (12.9) 46.4 (12.2) <0.001 54.2 (16.7) 52.2 (15.4) 50.4 (14.7) <0.001
Triglycerides, mg/dL 97.2 (75.2) 107.3 (70.3) 109.9 (59.5) <0.001 133.0 (83.7) 135.3 (72.2) 160.5 (94.9) <0.001 155.6 (111.6) 162.4 (109.2) 154.5 (80.9) 0.82 117.8 (69.4) 133.6 (105.1) 147.3 (90.6) <0.001
Creatinine, mg/dL 1.0 (0.2) 1.0 (0.2) 1.0 (0.3) <0.001 0.9 (0.2) 0.9 (0.2) 0.9 (0.3) 0.03 0.9 (0.2) 0.9 (0.2) 0.9 (0.4) 0.68 0.9 (0.2) 1.0 (0.2) 1.0 (0.2) <0.001
Glomerular Filtration Rate (GFR) 88.4 (17.0) 85.9 (18.5) 84.8 (21.7) 0.43 85.2 (14.1) 83.0 (16.4) 78.7 (18.5) 0.3 83.6 (15.8) 83.9 (17.4) 82.7 (21.0) 0.005 78.3 (20.4) 75.6 (13.8) 73.8 (15.9) 0.15
Current Smoker, % Yes 13 17 23 <0.001 3 6 8 <0.001 9 14 18 <0.001 8 11 15 <0.001
Current Use of Alcohol, % Yes 52 51 46 0.58 34 32 28 0.45 51 49 43 0.56 76 73 66 <0.001
Antilipidemic Therapy, % Yes 15 16 19 0.91 9 14 20 0.02 12 13 14 0.22 15 18 22 0.008
Statin Use, % Yes 14 15 18 0.89 9 12 17 0.4 11 12 13 0.25 14 16 20 0.05
Hypertension Medication Use, % Yes 40 49 62 <0.001 18 28 40 <0.001 24 31 42 <0.001 24 33 42 <0.001
Calcium Channel Blockers, % Yes 18 17 28 0.005 5 10 14 0.03 9 9 14 0.03 6 6 11 0.01
Angiotensin Type 2 Antagonists 4 3 5 0.36 3 4 9 0.07 1 3 4 0.02 2 2 4 0.1
Aspirin Use, % Yes 29 30 33 0.51 10 21 24 0.03 23 26 30 0.61 35 41 42 0.55
Diabetes Medication Use, % Yes 80 74 83 0.31 67 79 72 0.85 66 84 82 0.12 47 70 75 0.26
Diuretic Use, % Yes 18 21 26 0.17 2 5 6 0.004 5 8 12 0.004 7 12 21 <0.001
Females Only
Hormone Replacement Therapy, % Yes 55 45 40 0.004 44 31 28 0.09 45 41 34 0.76 68 69 57 <0.001
Post-menopause, % Yes 82 85 87 0.65 78 85 94 0.55 82 90 90 0.95 79 85 90 0.33

GFR, glomerular filtration rate; HDL, high-density lipoproteins; HGF, hepatocyte growth factor.

p Values from a linear regression model adjusted for age and sex.